Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906494403> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2906494403 endingPage "S187" @default.
- W2906494403 startingPage "S186" @default.
- W2906494403 abstract "To compare the time elapsed from European Medicines Agency (EMA) authorisation to national commercialization and price differences of biosimilar drugs in five European countries (EU5). The panel is constituted by authorized biosimilars, extracted from EMA website. Commercialization dates in each country were collected through the official sources. Differences from EMA authorisation to national commercialization were evaluated. In addition, variations in drug prices between the EU5 were assessed considering ex-factory prices. For each country, official price sources were consulted for the respective prices (2018 €). From April-2006 to January-2018 EMA authorized 39 biosimilars for 15 active substances. It was observed that some 33% (n=13) of the total biosimilars authorized had not been commercialized yet in at least one of the EU5 countries, in some cases due to existing patents. 36% (n=14) of the biosimilars authorized have been launched in all EU5 countries. For biosimilars with an available commercialization date for all EU5, the median time elapsed from EMA authorisation to national commercialization was 4.47 months (range 0.13-27.35) in the UK; 5.85 months (range 0.72-25.15) in Germany; 8.58 months (range 4.31-26.70) in Spain; 13.48 months (range 5.42-31.73) in France and 15.32 months (range 6.54-35.08) in Italy. High variations on the average price were observed for some of the biosimilars launched in all EU5. The joint analysis of EU5 is important in order to understand differences of market access processes across countries and implement strategies accordingly. The analysis has considered the country regulation and a variability in access and prices of approved biosimilars in different EU5 countries has been found." @default.
- W2906494403 created "2019-01-01" @default.
- W2906494403 creator A5016092372 @default.
- W2906494403 creator A5028628616 @default.
- W2906494403 creator A5043460705 @default.
- W2906494403 creator A5043922403 @default.
- W2906494403 creator A5070267156 @default.
- W2906494403 date "2018-10-01" @default.
- W2906494403 modified "2023-09-30" @default.
- W2906494403 title "PHP217 - TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5" @default.
- W2906494403 doi "https://doi.org/10.1016/j.jval.2018.09.1111" @default.
- W2906494403 hasPublicationYear "2018" @default.
- W2906494403 type Work @default.
- W2906494403 sameAs 2906494403 @default.
- W2906494403 citedByCount "0" @default.
- W2906494403 crossrefType "journal-article" @default.
- W2906494403 hasAuthorship W2906494403A5016092372 @default.
- W2906494403 hasAuthorship W2906494403A5028628616 @default.
- W2906494403 hasAuthorship W2906494403A5043460705 @default.
- W2906494403 hasAuthorship W2906494403A5043922403 @default.
- W2906494403 hasAuthorship W2906494403A5070267156 @default.
- W2906494403 hasBestOaLocation W29064944031 @default.
- W2906494403 hasConcept C100001284 @default.
- W2906494403 hasConcept C108759981 @default.
- W2906494403 hasConcept C126322002 @default.
- W2906494403 hasConcept C144133560 @default.
- W2906494403 hasConcept C162324750 @default.
- W2906494403 hasConcept C162853370 @default.
- W2906494403 hasConcept C2780625559 @default.
- W2906494403 hasConcept C2910862244 @default.
- W2906494403 hasConcept C38652104 @default.
- W2906494403 hasConcept C41008148 @default.
- W2906494403 hasConcept C59491497 @default.
- W2906494403 hasConcept C71924100 @default.
- W2906494403 hasConceptScore W2906494403C100001284 @default.
- W2906494403 hasConceptScore W2906494403C108759981 @default.
- W2906494403 hasConceptScore W2906494403C126322002 @default.
- W2906494403 hasConceptScore W2906494403C144133560 @default.
- W2906494403 hasConceptScore W2906494403C162324750 @default.
- W2906494403 hasConceptScore W2906494403C162853370 @default.
- W2906494403 hasConceptScore W2906494403C2780625559 @default.
- W2906494403 hasConceptScore W2906494403C2910862244 @default.
- W2906494403 hasConceptScore W2906494403C38652104 @default.
- W2906494403 hasConceptScore W2906494403C41008148 @default.
- W2906494403 hasConceptScore W2906494403C59491497 @default.
- W2906494403 hasConceptScore W2906494403C71924100 @default.
- W2906494403 hasLocation W29064944031 @default.
- W2906494403 hasOpenAccess W2906494403 @default.
- W2906494403 hasPrimaryLocation W29064944031 @default.
- W2906494403 hasRelatedWork W2519154535 @default.
- W2906494403 hasRelatedWork W2571592438 @default.
- W2906494403 hasRelatedWork W2582464732 @default.
- W2906494403 hasRelatedWork W2762624513 @default.
- W2906494403 hasRelatedWork W2891540343 @default.
- W2906494403 hasRelatedWork W2903995216 @default.
- W2906494403 hasRelatedWork W3005038264 @default.
- W2906494403 hasRelatedWork W3071387528 @default.
- W2906494403 hasRelatedWork W3129999421 @default.
- W2906494403 hasRelatedWork W3184988574 @default.
- W2906494403 hasVolume "21" @default.
- W2906494403 isParatext "false" @default.
- W2906494403 isRetracted "false" @default.
- W2906494403 magId "2906494403" @default.
- W2906494403 workType "article" @default.